Neogen Corp., a provider of food and animal safety solutions, announces that James P. Tobin will retire from its board of directors, effective May 31, 2025. Tobin has served on the board since 2016 and currently chairs the Governance and Sustainability Committee while also serving on the Audit Committee.
“On behalf of the entire board and leadership team, I want to thank Jim for his nine years of service and steadfast commitment to Neogen,” said James C. Borel, chair of the Neogen board of directors. “Jim has played a key leadership role during a period of growth and transformation, helping to position the company for long-term value creation.”
Borel will assume the role of interim chair of the Governance and Sustainability Committee until a permanent successor is named.
Stepping into the board role is Andrea Wainer, who will join the company’s board of directors on June 1, 2025. Wainer brings over 25 years of experience in diagnostics and healthcare, most recently serving as executive vice president of Rapid and Molecular Diagnostics at Abbott Laboratories.
She also holds a board position at Analog Devices, Inc., where she serves on the Nominations and Governance Committee.
“We are thrilled to welcome Andrea to Neogen’s board,” said Borel. “Her deep expertise in molecular diagnostics, along with her strong background in finance and operational leadership, will be a tremendous asset as we continue advancing Neogen’s mission to be the leader in food safety solutions. Additionally, her perspective as a public company director adds important value to our Board at this stage in our evolution.”
